Ken Griffin Avid Bioservices, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 50,500 shares of CDMO stock, worth $360,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,500

Previous 15,600 223.72%

Holding current value

$360,570

Previous $101,000 234.65%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.86 - $8.79 $8.15 Million - $12.2 Million	1,390,252 Added 488.08%	1,675,094 $11.2 Million
Q4 2023 Feb 14, 2024	SELL	$4.64 - $9.56 $3.5 Million - $7.21 Million	-754,479 Reduced 72.59%	284,842 $1.85 Million
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $8.71 Million - $13 Million	926,903 Added 824.51%	1,039,321 $9.81 Million
Q2 2023 Aug 14, 2023	BUY	$12.96 - $20.93 $921,909 - $1.49 Million	71,135 Added 172.31%	112,418 $1.57 Million
Q1 2023 May 15, 2023	SELL	$13.48 - $18.79 $49,849 - $69,485	-3,698 Reduced 8.22%	41,283 $774,000

Q4 2022 Feb 14, 2023	BUY	$12.61 - $18.74 $308,465 - $458,417	24,462 Added 119.22%	44,981 $619,000
Q3 2022 Nov 14, 2022	BUY	$15.33 - $20.36 $314,556 - $417,766	20,519 New	20,519 $392,000
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $1.12 Million - $1.87 Million	67,556 Added 581.68%	79,170 $1.61 Million
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $2.2 Million - $3.62 Million	-106,056 Reduced 90.13%	11,614 $338,000
Q3 2021 Nov 15, 2021	BUY	$19.05 - $28.32 $1.09 Million - $1.62 Million	57,033 Added 94.06%	117,670 $2.54 Million
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $1.45 Million - $1.97 Million	-76,849 Reduced 55.9%	60,637 $1.56 Million
Q1 2021 May 17, 2021	SELL	$11.86 - $21.77 $527,781 - $968,786	-44,501 Reduced 24.45%	137,486 $2.51 Million
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $96,374 - $156,325	13,293 Added 7.88%	181,987 $2.1 Million
Q3 2020 Nov 16, 2020	BUY	$6.53 - $8.6 $949,344 - $1.25 Million	145,382 Added 623.64%	168,694 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$4.11 - $6.78 $32,711 - $53,962	7,959 Added 51.84%	23,312 $153,000
Q1 2020 May 15, 2020	SELL	$3.15 - $7.39 $119,564 - $280,502	-37,957 Reduced 71.2%	15,353 $78,000
Q4 2019 Feb 14, 2020	SELL	$5.01 - $8.16 $210,264 - $342,467	-41,969 Reduced 44.05%	53,310 $409,000
Q2 2019 Aug 14, 2019	BUY	$3.43 - $5.6 $78,324 - $127,875	22,835 Added 31.52%	95,279 $533,000
Q4 2018 Feb 14, 2019	SELL	$4.04 - $6.75 $67,476 - $112,738	-16,702 Reduced 18.74%	72,444 $297,000
Q3 2018 Nov 13, 2018	BUY	$4.28 - $7.32 $50,944 - $87,129	11,903 Added 15.41%	89,146 $0
Q2 2018 Aug 10, 2018	BUY	$3.1 - $3.93 $37,252 - $47,226	12,017 Added 18.42%	77,243 $0
Q1 2018 May 11, 2018	BUY	$2.32 - $4.22 $151,324 - $275,253	65,226 New	65,226 $190,000

Others Institutions Holding CDMO

# of Institutions

176

Shares Held

64.8M

Call Options Held

50.5K

Put Options Held

102K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $444M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account